← Back to Search

tDCS + Cognitive Training for Improved Decision Making (tDCS-CTDM Trial)

N/A
Recruiting
Led By Najat Khalifa, MD
Research Sponsored by Dr. Najat Khalifa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Consenting volunteers aged between 18 and 40.
Consenting volunteers aged between 18 and 40
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline after 20 minutes of combined cognitive training and tdcs stimulation
Awards & highlights

tDCS-CTDM Trial Summary

This trial will test if a brain stimulation technique called tDCS combined with cognitive training can improve decision making and impulse control.

Who is the study for?
This trial is for consenting adults aged 18 to 40 who want to help study decision-making and impulsivity. It's not suitable for those with epilepsy, other neurological conditions, significant head injury history, substance misuse issues, major mental disorders, or those on psychotropic medication.Check my eligibility
What is being tested?
The study tests if brain stimulation (anodal tDCS) combined with cognitive training improves decision-making and impulse control compared to a fake treatment (sham tDCS). Participants will do tasks like the Iowa Gambling Task while receiving these treatments.See study design
What are the potential side effects?
tDCS may cause mild side effects such as tingling, itching or discomfort at the electrode site. Cognitive training has no known side effects but can be mentally taxing.

tDCS-CTDM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 40 years old and agree to participate.
Select...
I am between 18 and 40 years old.

tDCS-CTDM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Iowa Gambling Task (IGT) net scores
Secondary outcome measures
Abbreviated Profile of Mood States (POMS) Total Mood Disturbance score
Stop Signal Task (SST) reaction time
Urgency, Perseveration, Premeditation, Sensation Seeking + Positive Urgency (UPPS+P) Impulsive Behavior Scale total scores

tDCS-CTDM Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Combined anodal tDCS and cognitive trainingExperimental Treatment2 Interventions
Combined anodal tDCS and cognitive training. Anodal tDCS will be delivered while the participant is completing the cognitive training task (Iowa Gambling Task). Anodal tDCS will use a constant current of 2mA, delivered via gradual increase and decrease over 10 seconds at the onset and offset of stimulation (current ramps), respectively. The duration of each tDCS session will be 20 minutes.
Group II: Combined sham tDCS and cognitive trainingPlacebo Group2 Interventions
Combined sham tDCS and cognitive training. Sham tDCS will be delivered while the participant is completing the cognitive training task (Iowa Gambling Task). For sham tDCS, the current will be delivered only in the first 10 seconds, after which the stimulation will cease but with the electrodes still in place throughout the session. The duration of each tDCS session will be 20 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive training
2019
Completed Phase 3
~1480

Find a Location

Who is running the clinical trial?

Dr. Najat KhalifaLead Sponsor
1 Previous Clinical Trials
60 Total Patients Enrolled
University of NottinghamOTHER
503 Previous Clinical Trials
2,262,837 Total Patients Enrolled
Najat Khalifa, MDPrincipal InvestigatorQueen's University - Canada

Media Library

Cognitive training Clinical Trial Eligibility Overview. Trial Name: NCT03886025 — N/A
Decision Making Research Study Groups: Combined anodal tDCS and cognitive training, Combined sham tDCS and cognitive training
Decision Making Clinical Trial 2023: Cognitive training Highlights & Side Effects. Trial Name: NCT03886025 — N/A
Cognitive training 2023 Treatment Timeline for Medical Study. Trial Name: NCT03886025 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must a patient meet to be eligible for this clinical research?

"This clinical trial is looking for 60 volunteers aged between 18 and 40 who are willing to consent. Candidates should meet the following criteria: of age and with decision-making capacity within the aforementioned range."

Answered by AI

Is this experiment taking partakers who are octogenarians or beyond?

"As per the criteria for this medical trial, participants must be aged 18 or over and no more than 40 years old."

Answered by AI

Are enrollees still being accepted for this research initiative?

"The clinical trial's details on the clinicaltrials.gov website demonstrate that this study is currently enrolling volunteers. The first posting was made on September 15th 2022, followed by a recent update to the data from July 28th 2022."

Answered by AI

What is the maximum enrollment capacity for this medical experiment?

"Affirmative. According to clinicaltrials.gov, this experiment is at present enrolling patients. The trial was initially published on September 15th 2022 and updated the last time on July 28th 2022 with a recruitment goal of 60 from one single medical centre."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
~22 spots leftby Mar 2025